Heron Therapeutics Inc

NEW
STU:AXD2 (USA)   Ordinary Shares
€ 0.26 -0.0048 (-1.81%) Aug 20
At Loss
P/B:
9.97
Market Cap:
€ 50.26M ($ 58.69M)
Enterprise V:
€ 141.70M ($ 165.48M)
Volume:
1.73K
Avg Vol (2M):
9.67K
Trade In:
Volume:
1.73K
At Loss

Heron Therapeutics Inc (STU:AXD2) Dividend

Heron Therapeutics Inc (STU:AXD2) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -16.5%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:AXD2 Dividend

Does Heron Therapeutics Inc (STU:AXD2) pay a dividend?

Heron Therapeutics Inc (STU:AXD2) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Heron Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Heron Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -16.5% over the past 3 years.

What are dividend-paying alternatives to Heron Therapeutics Inc?

For dividend-paying alternatives in Heron Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.